Outlook Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.07
|
-0.06
|
0.01
|
14.29%
|
|
2022-06-30
|
-0.07
|
-0.08
|
-0.01
|
-14.29%
|
|
2022-03-31
|
-0.06
|
-0.09
|
-0.03
|
-50.00%
|
|
2021-12-31
|
-0.06
|
-0.08
|
-0.02
|
-33.33%
|
|
2021-09-30
|
-0.06
|
-0.09
|
-0.03
|
-50.00%
|
|
2021-06-30
|
-0.07
|
-0.07
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.08
|
-0.09
|
-0.01
|
-12.50%
|
|
2020-12-31
|
-0.08
|
-0.12
|
-0.04
|
-50.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-0.31
|
|
2021-09-30
|
-0.37
|
|
2020-09-30
|
-1.14
|
|
2019-09-30
|
-1.66
|
|
2018-09-30
|
-6.96
|
|
2017-09-30
|
-7.78
|
|
2016-09-30
|
-4.78
|